Pumeirui Biotech develops AI-driven algorithms for predicting the structures of protein-RNA and protein-ligand complexes, significantly enhancing the efficiency of drug discovery processes. The platform reduces the time and cost associated with identifying potential active compounds for targeted cancer therapies.
Funding
Funding not disclosed
Founders
Product
Problem
The drug discovery process is often slowed down and made more expensive by the challenges of accurately predicting the structures of protein-RNA and protein-ligand complexes. Identifying potential active compounds for targeted therapies requires significant time and resources.
Solution
Pumeirui Biotech offers an AI-driven cloud platform that provides a suite of computational tools and services to streamline drug discovery. The platform utilizes proprietary algorithms to predict the structures of protein-RNA, protein-DNA, protein-peptide, and protein-ligand complexes, facilitating the identification of potential drug candidates. In addition to structure prediction, Pumeirui offers virtual screening, molecular docking, and molecular dynamics simulation tools. The platform also provides custom modeling services and traditional biochemical and cell-based assay services, offering a comprehensive solution for preclinical drug development.
Target Audience
Pumeirui Biotech serves pharmaceutical companies, biotech firms, and research institutions involved in drug discovery and development.
Features
- AI-driven algorithms for predicting protein-RNA, protein-DNA, protein-peptide, and protein-ligand complex structures
- Virtual screening tools for identifying potential active molecules from chemical libraries
- Molecular docking tools for predicting binding modes of molecules to target proteins
- Molecular dynamics simulation tools for predicting the stability of protein complexes and binding affinities
- PROTAC design tools for predicting ternary complex structures and evaluating linker designs
- Custom modeling services tailored to specific research needs
- Biochemical and cell-based assay services, including cell growth curves, invasion assays, and protein stability measurements